AAAAAA

   
Results: 1-21 |
Results: 21
Expression profile of human herpesvirus 8 (HHV-8) in pyothorax associated lymphoma and in effusion lymphoma
Authors: O'Donovan, M Silva, I Uhlmann, V Bermingham, N Luttich, K Martin, C Sheils, O Killalea, A Kenny, C Pileri, S O'Leary, JJ
Citation: M. O'Donovan et al., Expression profile of human herpesvirus 8 (HHV-8) in pyothorax associated lymphoma and in effusion lymphoma, J CL PATH-M, 54(2), 2001, pp. 80-85
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results
Authors: Zinzani, PL Stefoni, V Tani, M Barbieri, E Albertini, P Vigna, E Gherlinzoni, F Alinari, L Galuppi, A Pileri, S Babini, L Tura, S
Citation: Pl. Zinzani et al., MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results, LEUK LYMPH, 42(5), 2001, pp. 989-995
Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer
Authors: Mattioli, S D'Ovidio, F Tazzari, P Pilotti, V Daddi, N Bandini, G Piccioli, M Pileri, S
Citation: S. Mattioli et al., Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer, EUR J CAR-T, 19(5), 2001, pp. 576-579
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
Authors: Teofili, L Di Febo, AL Pierconti, F Maggiano, N Bendandi, M Rutella, S Cingolani, A Di Renzo, N Musto, P Pileri, S Leone, G Larocca, LM
Citation: L. Teofili et al., Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease, BLOOD, 97(4), 2001, pp. 1063-1069
Multivisceral eosinophilic fibrosis: a new clinical presentation
Authors: Gullo, L Golfieri, R Orcioni, GF Pileri, S
Citation: L. Gullo et al., Multivisceral eosinophilic fibrosis: a new clinical presentation, EUR J GASTR, 12(9), 2000, pp. 1037-1039
Efficacy of rituximab in hairy cell leukemia treatment
Authors: Zinzani, PL Ascani, S Piccaluga, PP Bendandi, M Pileri, S Tura, S
Citation: Pl. Zinzani et al., Efficacy of rituximab in hairy cell leukemia treatment, J CL ONCOL, 18(22), 2000, pp. 3875-3877
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine
Authors: Zinzani, PL Magagnoli, M Bendandi, M Tani, M Stefoni, V Cellini, C Poggi, S Piccioli, M Pileri, S Tura, S
Citation: Pl. Zinzani et al., Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine, HAEMATOLOG, 85(9), 2000, pp. 922-925
Expression of the CD30 antigen in non-lymphoid tissues and cells
Authors: Durkop, H Foss, HD Eitelbach, F Anagnostopoulos, I Latza, U Pileri, S Stein, H
Citation: H. Durkop et al., Expression of the CD30 antigen in non-lymphoid tissues and cells, J PATHOLOGY, 190(5), 2000, pp. 613-618
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity
Authors: Leoncini, L Lazzi, S Scano, D Mura, A Onida, A Massarelli, G Tosi, P Barbini, P Cevenini, G Massai, MR Pileri, S Falini, B Giordano, A Kraft, R Laissue, JA Cottier, H
Citation: L. Leoncini et al., Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity, INT J CANC, 86(6), 2000, pp. 777-781
Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas
Authors: Haralambieva, E Pulford, KAF Lamant, L Pileri, S Roncador, G Gatter, KC Delsol, G Mason, DY
Citation: E. Haralambieva et al., Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas, BR J HAEM, 109(3), 2000, pp. 584-591
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Authors: Stein, H Foss, HD Durkop, H Marafioti, T Delsol, G Pulford, K Pileri, S Falini, B
Citation: H. Stein et al., CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features, BLOOD, 96(12), 2000, pp. 3681-3695
A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 proteinin a subset of germinal center B cells, plasma cells, and activated T cells
Authors: Falini, B Fizzotti, M Pucciarini, A Bigerna, B Marafioti, T Gambacorta, M Pacini, R Alunni, C Natali-Tanci, L Ugolini, B Sebastiani, C Cattoretti, G Pileri, S Dalla-Favera, R Stein, H
Citation: B. Falini et al., A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 proteinin a subset of germinal center B cells, plasma cells, and activated T cells, BLOOD, 95(6), 2000, pp. 2084-2092
Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia - Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma
Authors: De Vita, S De Re, V Gasparotto, D Ballare, M Pivetta, B Ferraccioli, G Pileri, S Boiocchi, M Monteverde, A
Citation: S. De Vita et al., Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia - Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma, ARTH RHEUM, 43(1), 2000, pp. 94-102
Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma
Authors: Ferri, C Pileri, S Zignego, AL
Citation: C. Ferri et al., Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma, INFEC DIS S, 2000, pp. 349-368
Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia - A phase III, randomized, multicenter study
Authors: Mandelli, F Lauria, F Majolino, I Meloni, G Santini, G Foa, R Castoldi, G Corradini, P Falini, B Pileri, S Liso, V
Citation: F. Mandelli et al., Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia - A phase III, randomized, multicenter study, HEM CELL TH, 41(3), 1999, pp. 117-125
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas:Distinct mechanisms of cell growth control
Authors: Leoncini, L Bellan, C Cossu, A Claudio, PP Lazzi, S Cinti, C Cevenini, G Megha, T Laurini, L Luzi, P Orcioni, GF Piccioli, M Pileri, S Giardino, C Tosi, P Giordano, A
Citation: L. Leoncini et al., Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas:Distinct mechanisms of cell growth control, CLIN CANC R, 5(12), 1999, pp. 4065-4072
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that growsin SCID-mice with the morphologic features of a CD30(+) anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
Authors: Tazzari, PL de Totero, D Bolognesi, A Testoni, N Pileri, S Roncella, S Reato, G Stein, H Gobbi, M Stirpe, F
Citation: Pl. Tazzari et al., An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that growsin SCID-mice with the morphologic features of a CD30(+) anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins, HAEMATOLOG, 84(11), 1999, pp. 988-995
Immunohistochemical expression of internal and external ErbB-2 domains in invasive breast cancer
Authors: Ceccarelli, C Santini, D Gamberini, M Taffurelli, M Chieco, P Piana, S Pileri, S Marrano, D
Citation: C. Ceccarelli et al., Immunohistochemical expression of internal and external ErbB-2 domains in invasive breast cancer, BREAST CANC, 58(2), 1999, pp. 107-114
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: A multivariate cluster analysis
Authors: Leoncini, L Cossu, A Megha, T Bellan, C Lazzi, S Luzi, P Tosi, P Barbini, P Cevenini, G Pileri, S Giordano, A Kraft, R Laissue, JA Cottier, H
Citation: L. Leoncini et al., Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: A multivariate cluster analysis, INT J CANC, 83(2), 1999, pp. 203-209
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
Authors: Falini, B Pulford, K Pucciarini, A Carbone, A De Wolf-Peeters, C Cordell, J Fizzotti, M Santucci, A Pelicci, PG Pileri, S Campo, E Ott, G Delsol, G Mason, DY
Citation: B. Falini et al., Lymphomas expressing ALK fusion protein(s) other than NPM-ALK, BLOOD, 94(10), 1999, pp. 3509-3515
ALK(+) lymphoma: Clinico-pathological findings and outcome
Authors: Falini, B Pileri, S Zinzani, PL Carbone, A Zagonel, V Wolf-Peeters, C Verhoef, G Menestrina, F Todeschini, G Paulli, M Lazzarino, M Giardini, R Aiello, A Foss, HD Araujo, I Fizzotti, M Pelicci, PG Flenghi, L Martelli, MF Santucci, A
Citation: B. Falini et al., ALK(+) lymphoma: Clinico-pathological findings and outcome, BLOOD, 93(8), 1999, pp. 2697-2706
Risultati: 1-21 |